We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$81B
AUM Growth
+$6.66B
(+9%)
Cap. Flow
+$1.82B
Cap. Flow
% of AUM
2.24%
Top 10 Holdings %
Top 10 Hldgs %
22.31%
Holding
3,027
New
17
Increased
2,329
Reduced
595
Closed
62
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$164M |
| 2 |
Microsoft
MSFT
|
+$157M |
| 3 |
Amazon
AMZN
|
+$75.7M |
| 4 |
Tesla
TSLA
|
+$50M |
| 5 |
GE HealthCare
GEHC
|
+$45.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$33M |
| 2 |
STOR
STORE Capital Corporation
STOR
|
+$26.2M |
| 3 |
SIVB
SVB Financial Group
SIVB
|
+$24.9M |
| 4 |
Fair Isaac
FICO
|
+$17M |
| 5 |
LHCG
LHC Group LLC
LHCG
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.37% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 12.66% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Industrials | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIG
2726
DELISTED
Trean Insurance Group, Inc. Common Stock
TIG
| $213K | ﹤0.01% |
34,727
-249
| -0.7% | -$1.51K |
|
2727
Nature's Sunshine
NATR
$288M
| $212K | ﹤0.01% |
20,732
+444
| +2% | +$4.37K |
|
2728
Vera Therapeutics
VERA
$2.36B
| $212K | ﹤0.01% |
27,294
+9,241
| +51% | +$71.3K |
|
2729
C4 Therapeutics
CCCC
$412M
| $211K | ﹤0.01% |
67,088
+2,786
| +4% | +$16.4K |
|
|
MAGN
2730
Magnera Corp
MAGN
$460M
| $211K | ﹤0.01% |
5,098
-59
| -1% | -$2.72K |
|
2731
Liberty Global Class C
LBTYK
$3.49B
| $208K | ﹤0.01% |
+10,202
| New | +$215K |
|
2732
Heron Therapeutics
HRTX
$92.9M
| $206K | ﹤0.01% |
136,445
+3,558
| +3% | +$8.91K |
|
|
DZSI
2733
DELISTED
DZS Inc. Common Stock
DZSI
| $206K | ﹤0.01% |
26,068
+4,025
| +18% | +$44.8K |
|
|
IGMS
2734
DELISTED
IGM Biosciences
IGMS
| $205K | ﹤0.01% |
14,935
+204
| +1% | +$4.22K |
|
2735
Biglari Holdings Class B
BH
$1.21B
| $204K | ﹤0.01% |
+1,207
| New | +$199K |
|
|
SKYT
2736
DELISTED
SkyWater Technology
SKYT
| $204K | ﹤0.01% |
17,936
+2,070
| +13% | +$23.2K |
|
2737
Advantage Solutions
ADV
$361M
| $203K | ﹤0.01% |
5,134
+74
| +1% | +$4.18K |
|
2738
ImmunityBio
IBRX
$8.1B
| $203K | ﹤0.01% |
111,774
-830
| -0.7% | -$2.58K |
|
|
ICVX
2739
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $201K | ﹤0.01% |
34,640
+621
| +2% | +$5.37K |
|
2740
Nautilus Biotechnolgy
NAUT
$115M
| $196K | ﹤0.01% |
70,780
+1,394
| +2% | +$2.92K |
|
2741
CS Disco
LAW
$279M
| $195K | ﹤0.01% |
29,393
+1,582
| +6% | +$11.3K |
|
2742
Universal Electronics
UEIC
$61.3M
| $195K | ﹤0.01% |
19,230
-20,555
| -52% | -$358K |
|
2743
Outlook Therapeutics
OTLK
$191M
| $194K | ﹤0.01% |
8,917
+1,642
| +23% | +$36.7K |
|
2744
Upland Software
UPLD
$15.4M
| $194K | ﹤0.01% |
4,515
+26
| +0.6% | +$1.8K |
|
|
RAD
2745
DELISTED
Rite Aid Corporation
RAD
| $194K | ﹤0.01% |
86,446
-1,420
| -2% | -$4.71K |
|
|
AHT
2746
Ashford Hospitality Trust
AHT
$21M
| $192K | ﹤0.01% |
5,974
-819
| -12% | -$41K |
|
|
NREF
2747
NexPoint Real Estate Finance
NREF
$342M
| $191K | ﹤0.01% |
12,187
-8
| -0.1% | -$140 |
|
|
KLRS
2748
Kalaris Therapeutics
KLRS
$96.8M
| $191K | ﹤0.01% |
2,104
-53
| -2% | -$6.75K |
|
2749
Organogenesis Holdings
ORGO
$239M
| $189K | ﹤0.01% |
88,704
-122,083
| -58% | -$302K |
|
|
AEVA
2750
Aeva Technologies
AEVA
$1.86B
| $188K | ﹤0.01% |
31,589
+3,651
| +13% | +$29.3K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, RhumbLine Advisers held 3,027 positions worth $81B, up 9% from $74.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q1 2023: portfolio turnover was 2.6%. RhumbLine Advisers opened 17 new positions and exited 62, leaving the 3,027-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q1 2023 buy was GE HealthCare: 633,417 shares worth $52M.
- RhumbLine Advisers added most to Apple in Q1 2023, an estimated $164M increase.
- RhumbLine Advisers's biggest Q1 2023 reduction was GE Aerospace, cutting an estimated $33M.
- RhumbLine Advisers fully exited STORE Capital Corporation in Q1 2023, selling an estimated $26.2M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $81B portfolio in Q1 2023.
- RhumbLine Advisers opened 17 new positions and closed 62 in Q1 2023.
- RhumbLine Advisers's portfolio value rose 9% quarter-over-quarter to $81B.
Based on RhumbLine Advisers's 13F filing for Q1 2023, filed 11 May 2023.